Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $37 from $38 and keeps an Overweight rating on the shares. The firm updated the company’s model after hosting management for meetings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper reaffirms view of high-single-digit FY25 adjusted EPS growth
- Keurig Dr Pepper Reaffirms 2025 Financial Guidance
- Keurig Dr Pepper: Strong Growth Potential and Undervalued Stock with Strategic Expansion
- Keurig Dr Pepper Approves Key Proposals at Annual Meeting
- Morgan Stanley sees ‘opportune entry point’ into Keurig Dr Pepper